Anebulo Pharmaceuticals News

Anebulo Pharmaceuticals: Strong Buy Rating Amid Promising Clinical Advances and Rapid FDA Track

TipRanksFeb 16 03:25

Rising Cannabis Hospitalizations and Leadership Transition Boost Anebulo Pharmaceuticals' Outlook: A Buy Rating Analysis

TipRanksOct 27, 2023 01:26

Anebulo Pharmaceuticals Analyst Ratings

BenzingaOct 3, 2023 23:50

HC Wainwright & Co. Reiterates Buy on Anebulo Pharmaceuticals, Maintains $6 Price Target

BenzingaSep 25, 2023 18:10

Anebulo Pharmaceuticals Analyst Ratings

BenzingaSep 25, 2023 18:09

Anebulo Pharmaceuticals Analyst Ratings

BenzingaSep 21, 2023 23:48

HC Wainwright & Co. Initiates Coverage On Anebulo Pharmaceuticals With Buy Rating, Announces Price Target of $6

BenzingaSep 18, 2023 18:33

Anebulo Pharmaceuticals Analyst Ratings

BenzingaSep 18, 2023 18:32

Anebulo Pharmaceuticals (ANEB) Has a New Rating From H.C. Wainwright

TipRanksSep 18, 2023 18:25

Benchmark Reiterates Speculative Buy on Anebulo Pharmaceuticals, Maintains $8 Price Target

BenzingaMay 18, 2023 21:39

Anebulo Pharmaceuticals Analyst Ratings

Benzinga Analyst RatingsFeb 14, 2023 21:32